Abstract

Controlled and local release of growth factors and nutrients from porous scaffolds is important for maintenance of cell survival, proliferation, and promotion of tissue regeneration. The purpose of the present research was to design a controlled release porous collagen-microbead hybrid scaffold with controlled pore structure capable of releasing insulin for application to cartilage tissue regeneration. Collagen-microbead hybrid scaffold was prepared by hybridization of insulin loaded PLGA microbeads with collagen using a freeze-drying technique. The pore structure of the hybrid scaffold was controlled by using preprepared ice particulates having a diameter range of 150–250 μm. Hybrid scaffold had a controlled pore structure with pore size equivalent to ice particulates and good interconnection. The microbeads showed an even spatial distribution throughout the pore walls. In vitro insulin release profile from the hybrid scaffold exhibited a zero order release kinetics up to a period of 4 weeks without initial burst release. Culture of bovine articular chondrocytes in the hybrid scaffold demonstrated high bioactivity of the released insulin. The hybrid scaffold facilitated cell seeding and spatial cell distribution and promoted cell proliferation.

Highlights

  • Hyaline articular cartilage is composed of abundant chondrocytes and limited progenitor cells sparsely embedded in nonvascular extracellular matrix (ECM)

  • Human recombinant insulin was microencapsulated in PLGA microbeads using a w-o-w double emulsion technique

  • A controlled release porous collagen-microbead hybrid scaffold having a controlled pore structure was prepared by Cumulative insulin release (%)

Read more

Summary

Introduction

Hyaline articular cartilage is composed of abundant chondrocytes and limited progenitor cells sparsely embedded in nonvascular extracellular matrix (ECM). Articular cartilage defects are very difficult to heal due to its limited ability of self-repair and regeneration [1,2,3]. Such defects if untreated may lead to the serious problem of osteoarthritis, a major clinical problem around the world [4, 5]. Current treatment methods for articular cartilage defects include abrasion arthroplasty, subchondral drilling, osteochondral allografting, and periosteal or perichondral tissue grafting [6, 7]. Cartilage tissue engineering using porous scaffolds, chondrocytes or human mesenchymal stem cells (hMSCs), and bioactive instructive cues has been evolved as an alternative and promising approach to treat cartilage defects [1,2,3, 6, 8]

Objectives
Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call